$85.75
-0.64-0.75%
Ult. Agg.: Oct 13, 11:35 AM
Edwards Lifesciences (EW) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Edwards Lifesciences (EW) ha pubblicato l'ultima previsione il luglio 23, 2026 per Q3 2026. La società ha previsto un utile per azione pari a $0.71 - $0.77, rispetto a una stima di consenso per l'EPS di $0.74. Edwards Lifesciences ha inoltre previsto ricavi pari a $1.63B - $1.71B per il periodo.
Rispetto alle previsioni precedenti, Edwards Lifesciences {{epsDirection}} ha modificato le sue previsioni di fatturato da un intervallo precedente di {{epsPriorRange}}.
Edwards Lifesciences ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Edwards Lifesciences. 40
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.74 | $0.73 | $0.62 | $0.59 |
| Actual | $0.78 | $0.78 | $0.58 | $0.67 |
| Surprise | +5.41% | +6.85% | -6.45% | +13.6% |
| Revenue | ||||
| Estimate | $1.70B | $1.59B | $1.54B | $1.50B |
| Actual | $1.74B | $1.65B | $1.57B | $1.55B |
| Surprise | +2.42% | +3.41% | +1.81% | +3.66% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.74 | $0.71 | $0.84 | $0.86 |
| Revenue | ||||
| Consensus | $1.68B | $1.70B | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Jul 23, 2026 | $0.78 | $0.74 | 5.41 % |
| Q1 | Apr 23, 2026 | $0.78 | $0.73 | 6.85 % |
| Q4 | Feb 10, 2026 | $0.58 | $0.62 | -6.45 % |
| Q3 | Oct 30, 2025 | $0.67 | $0.59 | 13.6 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Jul 23, 2026 | $1.74B | $1.70B | 2.42 % |
| Q1 | Apr 23, 2026 | $1.65B | $1.59B | 3.41 % |
| Q4 | Feb 10, 2026 | $1.57B | $1.54B | 1.81 % |
| Q3 | Oct 30, 2025 | $1.55B | $1.50B | 3.66 % |